Does Environmental Sustainability Warrant a Spot on ISPOR’s Value Flower: A Multistakeholder Debate

Moderator

Amr Makady, PharmD, PhD, Janssen-Cilag B.V., Breda, Netherlands

Speakers

Melissa Pegg, BSc, MSc, York Health Economics Consortium, York, United Kingdom; Jesper Juel-Helwig, Rigshospitalet, Denmark; Christoph Glaetzer, Janssen (J&J), Princeton, NJ, United States

Background: While traditional evaluations focus on clinical efficacy and cost-effectiveness, the potential environmental impact of medicines is gaining recognition as an important element that could influence decision-making and prioritization. Objective: This panel will debate whether and how environmental impact of health interventions could be incorporated into value frameworks. As societies, healthcare systems and industry increasingly confront challenges posed by climate change, it is essential to evaluate how environmental sustainability (henceforth: sustainability) may be factored into the societal value of health interventions. Discussion: Using polls & Q&A, we will explore critical questions such as: - Should sustainability be included alongside traditional value criteria like clinical efficacy and cost? - How can we effectively and holistically quantify the environmental impact of medicines? - What frameworks can serve as models for incorporating sustainability into decision-making? Conclusion: By examining the role of sustainability in value frameworks, participants will be equipped with diverse perspectives on how healthcare systems can best navigate the intersection of efficacy, cost, and environmental responsibility.

Code

041

Topic

Health Policy & Regulatory, Health Service Delivery & Process of Care, Health Technology Assessment

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×